Business lead researcher Wei-Ming Deng and co-workers describe that Fufangs have already been used for years and years in China to treat bone disorders. Recent medical trials have suggested these Fufangs effectively prevent osteoporosis in postmenopausal ladies, but data on long-term outcomes such as fractures and adverse events are lacking. Related StoriesStudy: Post hospital syndrome is significant risk factor for patients going through elective surgeryGlan Clwyd Hospital N Wales invest in Esaote's G-Scan MRI unit for weight-bearing scanningBoston Kids's and Rock Health team up to accelerate development of pediatric health technologiesTo address this, Deng and group conducted a 5-yr multicenter follow-up study in which postmenopausal women were given an oral natural Fufangdeveloped for prevention of postmenopausal osteoporosis or placebo .To Your Health!

Berkeley HeartLab enters into collaborative agreement Berkeley HeartLab , a subsidiary of Celera Company , today that it has entered into collaborative agreements with Geisinger INFIRMARY and Proven Diagnostics announced, a clinical laboratory provider launched by Geisinger Wellness System recently. The KIF6 gene encodes kinesin-like proteins 6 . Published clinical tests have shown a link between KIF6 and cardiovascular risk and statin advantage. This contract enables Proven Diagnostics and Geisinger INFIRMARY to offer a far more personal treatment strategy for all those with coronary disease. Testing beneath the agreement will be performed by BHL.